BioBridgeXAll companies

BioAtla, Inc.

Biotechnology company · San Diego, California, United States · Nasdaq: BCAB

BioAtla, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker BCAB. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $220,268 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $5.8 million sold in a notice filed in 2015.

www.bioatla.comProfile compiled from public records. Is this your company? Request a correction or update

BioAtla at a glance

Typebiotechnology company
HeadquartersSan Diego, California, United States
Stock listingNasdaq: BCAB
SEC industryBiological Products, (No Diagnostic Substances)
Employees (per SBIR records)30

What does BioAtla do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $220,268 in total (2016). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $5.8 million sold (2015).

Frequently asked questions about BioAtla

Where is BioAtla headquartered?

BioAtla, Inc. is headquartered in San Diego, California, United States.

What does BioAtla do?

BioAtla, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is BioAtla a public company?

Yes. BioAtla, Inc. trades on Nasdaq under the ticker BCAB.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.